CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 72 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $74,256,000 | +0.3% | 627,111 | 0.0% | 28.61% | +41.6% |
| Q4 2020 | $74,068,000 | -24.5% | 627,111 | -28.9% | 20.20% | -63.1% |
| Q3 2020 | $98,071,000 | +1.2% | 882,411 | -7.0% | 54.82% | +40.2% |
| Q2 2020 | $96,931,000 | -3.2% | 948,629 | +2.2% | 39.10% | +50.7% |
| Q1 2020 | $100,161,000 | +59.5% | 928,016 | +72.0% | 25.94% | +28.5% |
| Q4 2019 | $62,798,000 | +145.6% | 539,597 | +141.5% | 20.20% | +119.8% |
| Q3 2019 | $25,573,000 | +77.7% | 223,400 | +47.9% | 9.19% | +21.7% |
| Q2 2019 | $14,394,000 | -4.1% | 151,034 | -8.2% | 7.55% | -26.8% |
| Q1 2019 | $15,011,000 | +24.2% | 164,500 | +3.3% | 10.32% | -32.0% |
| Q4 2018 | $12,085,000 | +5.4% | 159,200 | +11.1% | 15.18% | +35.9% |
| Q3 2018 | $11,464,000 | – | 143,300 | – | 11.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 131,657 | $13,077,000 | 5.92% |
| Point72 Hong Kong Ltd | 103,797 | $10,310,000 | 3.49% |
| York Capital Management Global Advisors, LLC | 827,738 | $82,219,000 | 2.00% |
| Parametrica Management Ltd | 3,889 | $386,000 | 1.83% |
| Athos Capital Ltd | 35,266 | $3,503,000 | 1.19% |
| Hillhouse Capital Management | 618,391 | $61,425,000 | 1.05% |
| JUPITER ASSET MANAGEMENT LTD | 502,812 | $49,940,000 | 0.73% |
| Black Creek Investment Management Inc. | 240,232 | $23,862,000 | 0.73% |
| COMGEST GLOBAL INVESTORS S.A.S. | 243,652 | $24,202,000 | 0.54% |
| Temasek Holdings (Private) Ltd | 990,000 | $98,337,000 | 0.52% |